ACTRN12618000362291招募中未知
Determination of CALR mutation status based on peripheral blood immunohistochemistry and flow cytometry in patients with myeloproliferative neoplasms.
Dr Andrew Parker0 个研究点目标入组 20 人开始时间: 2018年3月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 —（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Identification of individual cancer mutations and analysis of their immunogenicityC00-C97Malignant neoplasmscancerDRKS00011790BioNTech SE1,000
进行中（未招募）
不适用
A study to assess the incidence in the UK of a change in a protein found in patients with newly diagnosed non-small cell lung cancer which has advanced or spread, and to investigate the quality of life of these patients when they receive treatment with erlotinib (Tarceva®) alone as a first treatment for this stage of their disease.EUCTR2010-021120-96-GBRoche Products Limited1,200
招募中
不适用
Elucidation of treatment-specific gene mutation by liquid biopsy in patients with soft tissue sarcomasadvanced soft tissue sarcomasJPRN-UMIN000038273Orthopaedic surgery, Nagoya University Hospital15
招募中
不适用
The identification of mutations associated with Serrated Polyposis SyndromeHyperplastic polyposis syndromeSerrated Polyposis Syndrome100180181001799010017991NL-OMON38510niversitair Medisch Centrum Sint Radboud100
招募中
不适用
Investigation of germline mutation analysis via novel gene panel in JapaHereditary cancer, Familial hypercholesterolemiaJPRN-UMIN000035395Tokyo Medical and Dental University Department of Medical Genetics150